Bristol-Myers Squibb Company

Stock Chart, Company Information, and Scan Results

$56.10(as of May 8, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Bristol-Myers Squibb Company Company Information, Fundamentals, and Technical Indicators

Stock Price$56.10
Ticker SymbolBMY
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees32,500
CountyUSA
Market Cap$114,866.5M
EBIDTA18,974.0M
10-Day Moving Average57.58
P/E Ratio15.78
20-Day Moving Average58.20
Forward P/E Ratio9.07
50-Day Moving Average58.78
Earnings per Share3.57
200-Day Moving Average51.31
Profit Margin23.31%
RSI40.41
Shares Outstanding2,042.1M
ATR1.35
52-Week High62.25
Volume9,964,497
52-Week Low41.46
Most Recent Support Level55.57
Book Value20,102.0M
Most Recent Resistance Level60.78
P/B Ratio5.71
Upper Keltner61.23
P/S Ratio2.37
Lower Keltner55.17
Debt-to-Equity Ratio61.23
Next Earnings DateUnknown
Cash Surplus-9,584.0M
Next Ex-Dividend DateUnknown

BMY takes the fight against disease to the heart, with leading cardiovascular medications like Camzyos—an FDA-approved treatment for obstructive hypertrophic cardiomyopathy. The global biopharmaceutical company is also well-known for its development of oncology and immunology products, including Opdivo and Yervoy for cancer treatment, and Orencia for rheumatoid arthritis. If you are looking to add a well-diversified biopharmaceutical stock to your portfolio, BMY could be the one.

Bristol-Myers Squibb Company In Our Stock Scanner

As of May 08, 2026
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.